SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008853
Filing Date
2022-05-16
Accepted
2022-05-16 07:15:48
Documents
59
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zyne-20220331x10q.htm   iXBRL 10-Q 976955
2 EX-31.1 zyne-20220331xex31d1.htm EX-31.1 11476
3 EX-31.2 zyne-20220331xex31d2.htm EX-31.2 11213
4 EX-32.1 zyne-20220331xex32d1.htm EX-32.1 6118
5 EX-32.2 zyne-20220331xex32d2.htm EX-32.2 6139
6 GRAPHIC zyne-20220331x10q001.jpg GRAPHIC 81187
  Complete submission text file 0001558370-22-008853.txt   4999968

Data Files

Seq Description Document Type Size
7 EX-101.SCH zyne-20220331.xsd EX-101.SCH 36821
8 EX-101.CAL zyne-20220331_cal.xml EX-101.CAL 42588
9 EX-101.DEF zyne-20220331_def.xml EX-101.DEF 145978
10 EX-101.LAB zyne-20220331_lab.xml EX-101.LAB 296906
11 EX-101.PRE zyne-20220331_pre.xml EX-101.PRE 250679
53 EXTRACTED XBRL INSTANCE DOCUMENT zyne-20220331x10q_htm.xml XML 896894
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37526 | Film No.: 22925421
SIC: 2834 Pharmaceutical Preparations